Avenue Therapeutics

-$0.0028 (-0.89%) Today
$0.00 (0.00%) As of 9:37 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXI and other ETFs, options, and stocks.

About ATXI

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain.

CEO
David Jin
Employees
4
Headquarters
New York, New York
Founded
2015

ATXI Key Statistics

Market cap
6.80M
Price-Earnings ratio
—
Dividend yield
—
Average volume
203.58K
High today
$0.348
Low today
$0.3042
Open price
$0.31
Volume
94.74K
52 Week high
$5.19
52 Week low
$0.20

ATXI Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.14 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure